Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

TSX:CHR - CA17040T8885 - Common Stock

20.32 CAD
+0.17 (+0.84%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

4

CHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 8 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
CHR had a positive operating cash flow in the past year.
In multiple years CHR reported negative net income over the last 5 years.
In the past 5 years CHR always reported a positive cash flow from operatings.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

The Return On Assets of CHR (-1.91%) is comparable to the rest of the industry.
CHR has a Return On Equity of -4.82%. This is comparable to the rest of the industry: CHR outperforms 50.00% of its industry peers.
The Return On Invested Capital of CHR (6.54%) is better than 100.00% of its industry peers.
CHR had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 5.44%.
The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

With a decent Operating Margin value of 6.87%, CHR is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR has declined.
The Gross Margin of CHR (65.48%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CHR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CHR has been increased compared to 5 years ago.
CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR has an Altman-Z score of 0.87. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.87, CHR is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
CHR has a debt to FCF ratio of 7.89. This is a slightly negative value and a sign of low solvency as CHR would need 7.89 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.89, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CHR has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR is somewhat dependend on debt financing.
CHR has a Debt to Equity ratio of 0.54. This is amongst the best in the industry. CHR outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 0.87
ROIC/WACC0.79
WACC8.28%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR has a Current Ratio of 1.14. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CHR (1.14) is better than 62.50% of its industry peers.
CHR has a Quick Ratio of 1.14. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
CHR's Quick ratio of 0.61 is in line compared to the rest of the industry. CHR outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.57%, which is quite impressive.
Measured over the past years, CHR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
Looking at the last year, CHR shows a very negative growth in Revenue. The Revenue has decreased by -13.36% in the last year.
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

The Earnings Per Share is expected to grow by 1.21% on average over the next years.
CHR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.14% yearly.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.03 indicates a reasonable valuation of CHR.
Based on the Price/Earnings ratio, CHR is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (27.13), we can say CHR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.54, the valuation of CHR can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 87.50% of the companies listed in the same industry.
CHR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 9.03
Fwd PE 10.54
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CHR is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.74
EV/EBITDA 4
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.59%, CHR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.83, CHR has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.32, CHR is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.59%

5.2 History

On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (8/29/2025, 7:00:00 PM)

20.32

+0.17 (+0.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap522.83M
Analysts78.18
Price Target28.6 (40.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.59%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-31 2025-07-31 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)1.31%
PT rev (3m)4.55%
EPS NQ rev (1m)-5.31%
EPS NQ rev (3m)1.35%
EPS NY rev (1m)-4.29%
EPS NY rev (3m)1.77%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)-2.45%
Revenue NY rev (1m)-2.42%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 9.03
Fwd PE 10.54
P/S 0.38
P/FCF 10.74
P/OCF 6.18
P/B 0.97
P/tB 0.99
EV/EBITDA 4
EPS(TTM)2.25
EY11.07%
EPS(NY)1.93
Fwd EY9.49%
FCF(TTM)1.89
FCFY9.31%
OCF(TTM)3.29
OCFY16.17%
SpS53.16
BVpS20.88
TBVpS20.54
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 0.87
F-Score5
WACC8.28%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%